RDD Europe 2011 Workshop 4 May 2011
|
|
- Merryl Reeves
- 6 years ago
- Views:
Transcription
1 RDD Europe 2011 Workshop 4 May 2011 This file represents the slides presented on May 4, 2011 by 3M Drug Delivery Systems at the RDD Europe 2011 Conference in Berlin, Germany. Slides have been modified to support electronic distribution in pdf form after the Conference. RDD Europe M DPI Workshop rev 3 FINAL PRESENTED SLIDES modified for post Workshop distribution.pptx
2 DPI Products: Design for Manufacturability and Scale-up (DFMSU) This Workshop will discuss considerations to ensure success during the various phases of development of dry powder inhaler (DPI) products. Topics will include: device design and development, the importance of a disciplined design control process, process design and development, unit cost estimating and the importance of an overall development map. Participants will leave with a deepened appreciation of the role that DFMSU plays in the development of DPI products. 2
3 Workshop Presenters Rich Sitz Stephen Stein 3
4 Workshop Outline Who is 3M Drug Delivery Systems? Why DFMSU? Design Controls DFMSU in Early & Late Stage Development Unit Cost Estimating Wrap Up/Discussion 4
5 Who is 3M Drug Delivery Systems? A Global Leader in Inhalation Drug Delivery 3M Drug Delivery Systems Division Leverages 3M Technologies and Manufacturing Expertise Partner API Over 50 years experience developing and manufacturing inhalation products 5
6 3M Dry Powder Inhaler Platforms 3M Taper Can contain up to 120 premetered doses. Uses active dispersion of drug to increase delivery efficiency. Delivers neat drug (no carrier powder required). When compared to in-vitro results from Advair Diskus, would deliver 50 to 70 percent less drug to a patient while delivering the same therapeutic dose to the lung (as defined by fine particle dose). 3M Conix Is available in single-dose disposable, single-dose reloadable, and multi-dose configurations. Efficiently leverages a patient's inspiratory flow to deagglomerate the drug powder. Has been used in a recently concluded Phase I clinical study, with excellent results. 6
7 Workshop Outline Who is 3M Drug Delivery Systems? Why DFMSU? Design Controls DFMSU in Early & Late Stage Development Unit Cost Estimating Wrap Up/Discussion 7
8 Why DFMSU? What could possibly go wrong during product development? Quality: poor performance. Cost: too expensive (development cost, capital equipment cost, product cost) Time: takes longer than planned. DFM is part of a disciplined process to help you meet your quality, cost and time goals. 8
9 Why DFMSU? high DFM is part of a robust development process to insure you can live long-term with today s decisions. low Development timeline 9
10 Workshop Outline Who is 3M Drug Delivery Systems? Why DFMSU? Design Controls DFMSU in Early & Late Stage Development Unit Cost Estimating Wrap Up 10
11 What are Design Controls? A formal methodology for management and documentation of product development projects Required for development of medical devices and combination products (drug + device) 21 CFR 820, ISO 9001/ISO 13485, ICH Q8 Key components: Design and Development Plan Design History File Design Requirements Specifications Device Specification (Design Input) Design Reviews Design Verification Design Validation Risk Management Process 11
12 Workshop Outline Who is 3M Drug Delivery Systems? Why DFMSU? Design Controls DFMSU in Early & Late Stage Development Unit Cost Estimating Wrap Up 12
13 Background Information Diskus/Accuhaler DPI Design Diskus/Accuhaler DPI developed by GSK Used in multiple drug products (including Advair) 60 dose blister strip ~12 mg of formulation (ordered blend using lactose monohydrate) Blister peeled prior to dosing to expose formulation Serevent, Diskus and Advair are registered to GlaxoSmithKline 13
14 Background Information - Taper DPI Design Microstructured carrier tape (MCT): MCT contains microstructure cavities filled with API Lactose carrier not required, can use neat drug Dose range of to 2 mg API per dose (fine particle doses between and 0.78 mg) Upon inhalation, spring impactor strikes tape and aerosolizes drug Multi-dose device: Up to 120 pre-metered doses with integrated moisture protection Patient-friendly features: Dose counter and dose ready-indicator Visual and audible feedback of dose delivery Simple, 3-step, breath-actuated delivery (open-inhaleclose) with a compact pocket-sized device 14 14
15 Applying DFMSU During Early Stages of Technology Development 15
16 Early Device Design Prototype Development Types of Prototypes: Industrial design prototypes (aka form study prototypes ) Subassembly breadboards Functional Prototypes ( Looks Like/Works Like models) Prototype Fabrication Techniques: Hand fabricating CNC machining Stereolithography (SLA) Rapid injection mold tooling Computer simulations (e.g. CFD, FEA, etc.) Many other techniques available 16
17 Process Development During Early Development Don t forget the processes! Many processes become locked in based on early device design decisions! Map out 20,000 foot view of manufacturing process: Sub-assembly strategy Facilities requirements Failure mode analysis of processes: Identify high priority processes Evaluate feasibility of high priority processes Focus early (limited) resources on these processes Preliminary assessment of process scaleability 17
18 20,000 Foot View of Taper Sub-Assembly Strategy MCT Moisture Control Chamber Subassembly Lower Housing Subassembly Final Assembly Labeling and Packaging MCT Moisture Control Chamber Subassembly Highest value subassembly Keep at 3M site to protect IP Lower Housing Subassembly Standard molded parts and routine pick-&-place assembly Provides manufacturing location flexibility 18
19 Taper DPI Process Development MCT Extrusion Dose determined by number and volume of dimples Control of dimple dimensions in MCT is crucial to controlling dose delivery MCT formed using extrusion embossing process 3M leverages this type of microreplication for many applications Nominally 230 mcg/dose MCT Nominally 1000 mcg/dose MCT Outcome: Demonstration of commercial capability. 19
20 Taper DPI Process Development MCT Coating Proprietary asynchronous roller coating method used to coat MCT High through-put process 1000 doses per minute Outcome: Demonstration of commercial capability. 20
21 Applying DFMSU During Later Stages of Technology Development 21
22 Taper DPI Process Development Threading of MCT through Small Opening Supply of MCT is stored on a spool in a moisture control chamber Chamber maintains RH at desired level Two concepts: (1) Window ; (2) 'Slot' 'Window' preferred for moisture protection; needed to demonstrate ability to thread MCT through window Worked with expert automation vendor to demonstrate PoC Ensure design provides acceptable performance & manufacturability Window Design Slot Design Outcome: Demonstration of high speed process. 22
23 Taper DPI Process Development Foil Sealing of Moisture Chamber Early development used conductive sealing Induction sealing highly desired for automation Unusual seal shape Constraints on foil selection PoC work initiated Utilized external experts Demonstrated acceptable seal performance and cycle times Reduced capital expenditure Outcome: Demonstration of high speed mfg process. 23
24 Design for Injection Molding 24
25 Design for Injection Molding Objectives Minimize cost of molded parts and mold tools Maximize molding reliability (complete shots, no flash, etc.) Utilize industry experts Critically review of every part for moldability Determine Type of Tooling Needed Capacity requirements Regulatory strategy 25
26 Design for Injection Molding No draft Part Attributes that Simplify Molding: Avoid undercuts & secondary tool actions Avoid parting lines on critical feature Place injection gates and ejection pins where they don t disrupt function or aesthetics Ejection pins location selected to ensure good ejection Sufficient draft angle to allow easy ejection Gate location and molding flow analyzed to ensure complete filling (particularly of narrow protrusions) These are guidelines 26
27 Design for Automated Assembly 27
28 Design for Automated Assembly Objectives: Minimize capital costs Maximize capacity of assembly equipment Maximize reliability / minimize down time ( Overall Equipment Efficiency ) Maximize flexibility Low and high volume assembly Location that sub-systems are assembled Keys to Success: Utilize industry experts 3-way interaction (design group, molding vendor, automation vendor) Critical review of every part 28
29 Design for Automated Assembly Part Attributes that Simplify Automated Assembly: Enables single axis (vertical) assembly Has good lead-ins Contain alignment features Design out misalignment/misplacement/tangling Avoid slower secondary process steps Make parts symmetrical when possible These are guidelines 29
30 Lead-In Features Diskus Mouthpiece Cover Mouthpiece cover pivots on small posts on the top and bottom housing. Mouthpiece cover has small receptacle for pivot posts. Tight fit required in order to prevent mouthpiece cover from falling off. 30
31 Lead-In Features Diskus Mouthpiece Cover Mouthpiece cover pivots on small posts on the top and bottom housing. Mouthpiece cover has small receptacle for pivot posts. Tight fit required in order to prevent mouthpiece cover from falling off. Simple lead in feature on posts allows for simple slide assembly. 31
32 Alignment Features Taper Dose Counter Correct orientation of parts is critical to function Can assemble with dose counter at 121, 61, or 31 Small hole in housing and dose counter wheels added Including simple pin hole feature improve assembly reliability 32
33 Alignment Features Taper Dose Counter Correct orientation of parts is critical to function Can assemble with dose counter at 121, 61, or 31 Small hole in housing and dose counter wheels added Including simple pin hole feature improved assembly reliability Including small flat features allows for self-alignment of parts in bowl feeder reduced capital costs Surface to enable alignment in bowl feeder 33
34 Single Axis Pick and Place Assembly - Diskus Blister Strip Assembly Lower Housing Assembly Final Assembly Labeling and Packaging 34
35 Single Axis Pick and Place Assembly - Diskus Molded parts simple to mold Simple single axis pick & place assembly Snap-fits hold parts in place Subassembly could be readily shipped to another location 35
36 Workshop Outline Who is 3M Drug Delivery Systems? Why DFMSU? Design Controls DFMSU in Early/Late Stage Development Unit Cost Estimating Wrap Up/Discussion 36
37 Unit Cost Estimating: Why? A unit cost estimate: 1. Is a critical input to many business processes: Required for Business Opportunity Assessments and Net Present Value calculations do we have a viable business? 2. Is a valuable tool in device and process design, development and scale-up: Gives clear visibility to cost contributors Allows identification and prioritization of future work 37
38 Unit Cost Estimating: Example 1. Create the unit cost calculation. 2. Interrogate the results. 38
39 Unit Cost Estimating: Create The following unit cost estimate is for illustration purposes only and is not intended to be representative of any commercial product or product in development. 1. Mix drug and lactose E-4 E-6 2. Fill into foil foil strip 3. Assemble into device 39
40 Unit Cost Estimating: Create 1. Mix drug and lactose E-4 E-6 2. Fill into foil foil strip 3. Assemble into device 40
41 Unit Cost Estimating: Create E-4 E-6 41
42 Unit Cost Estimating: Create E-4 E-6 42
43 Unit Cost Estimating: Interrogate Don t ignore the impact of Indirect Cost on the total factory cost of the product. Direct Costs: Can be allocated specifically to a product or batch. Indirect Costs: Are shared by multiple products. 43
44 Unit Cost Estimating: Interrogate Interrogate the variables that affect Mix Material cost. 44
45 Unit Cost Estimating: Interrogate What effect would increasing Mix Yield from 90% to 95% have on Unit Cost? 45
46 Unit Cost Estimating: Interrogate What effect would increasing ALL Yields from 90% to 95% have on Unit Cost? 46
47 Unit Cost Estimating: Interrogate Interrogate the variables that affect Fill Labor cost. 47
48 Unit Cost Estimating: Interrogate What effect would decreasing Fill Cycle Time from 10 sec/cycle to 5 sec/cycle have on Unit Cost? 48
49 Unit Cost Estimating: Benefit Provides direction and prioritization to your device and process development activities. 49
50 Unit Cost Estimating: Quantifying Uncertainty of Inputs Some inputs I understand very clearly: Example: 12 mg of lactose per dose. Some inputs have much more uncertainty: Example: Overall Equipment Efficiency: 75%? 50%? 90%? What do I do? Use Sensitivity Analysis to quantify the impact that the potential range of each input could have on Unit Cost. 50
51 Unit Cost Estimating: Sensitivity Analysis 51
52 Unit Cost Estimating: Sensitivity Analysis Sensitivity Analysis: Provides a Unit Cost estimate in the form of distribution, not just a single value. Gives visibility to those factors that have the largest contribution to that variability. 52
53 Unit Cost Estimating: Conclusion Provides development direction to shift the mean and reduce variability (risk). Is a valuable tool in DFMSU. 53
54 Workshop Outline Who is 3M Drug Delivery Systems? Why DFMSU? Design Controls DFMSU in Early/Late Stage Development Unit Cost Estimating Wrap Up/Discussion 54
55 DPI Products: Design for Manufacturability and Scale-up (DFMSU) Key Takeaways: Take advantage of Design Control disciplines starting with a detailed specification documents Prove critical processes early in development Leverage industry experts early Know your unit cost and let it support development planning. 55
56 DPI Products: Design for Manufacturability and Scale-up (DFMSU) This Workshop will discuss considerations to ensure success during the various phases of development of dry powder inhaler (DPI) products. Topics will include: device design and development, the importance of a disciplined design control process, process design and development, unit cost estimating and the importance of an overall development map. Participants will leave with a deepened appreciation of the role that DFMSU plays in the development of DPI products. 56
RDD Europe 2009 Workshop
RDD Europe 2009 Workshop 20 May 2009, Lisbon, Portugal This file is a redacted version of the presentation used during the Workshop and is suitable for electronic distribution. An Introduction to Differentiating
More informationDry Powder Inhaler. Developing an Efficient. 3M Conix DPI. White Paper / Spring Proven Solutions that Enable Your Success
3M Drug Delivery Systems Developing an Efficient Dry Powder Inhaler 3M Conix DPI White Paper / Spring 2011 Proven Solutions that Enable Your Success Introduction introduction Inhalation drug delivery has
More informationPerformance of a Fluticasone Propionate/Salmeterol Xinafoate 3M Taper DPI
3M Drug Delivery Systems Performance of a Fluticasone Propionate/Salmeterol Xinafoate 3M Taper DPI Poster Reprint / Spring 2011 John Simons 1, Herbert Chiou 1, Louis Sigtermans 1, Tom Robison 1, Debra
More information2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus
2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus Patient Perspective Alpha-1 1 Foundation John W. Walsh Patient Focus Personal perspective Challenges and lessons Importance
More informationDevice Change Management for Inhaled Products. Loy Britto, Ph.D. GlaxoSmithKline ISAM Congress Munich 2015
Device Change Management for Inhaled Products Loy Britto, Ph.D. GlaxoSmithKline ISAM Congress Munich 2015 Topics to be covered Update on ISO/TC 084/WG 15: Guidelines for development of drug products- Quality
More information040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers!
1. HOME PAGE Welcome to our world of Dry Powder Inhalers! Andi-Ventis Ltd, established in 2001 is a joint venture between Medochemie Ltd, Cyprus and Miat SpA Italy, founded to carry out the pharmaceutical
More informationGraft Delivery Devices
Graft Delivery Devices About Graft Delivery Devices Nordson MEDICAL Nordson MEDICAL is your partner in the global life sciences market providing innovative components, devices and custom OEM solutions
More informationDevice Design Similarity
Device Design Similarity Dave Parkins Director DPI Product Development PQRI Workshop on Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products. Bethesda March 9-10, 2009 Device Similarity
More informationSELECTING A DOSAGE FORM FOR DRUG DELIVERY TO THE LUNGS
SELECTING A DOSAGE FORM FOR DRUG DELIVERY TO THE LUNGS Poonam Sheth, PharmD, PhD, Research Scientist, Inhalation Matthew T. Marmura, Research Scientist, Inhalation Recipharm is frequently asked to help
More informationAppendix E: Device Technique
Adult Asthma Care Guidelines for Nurses: Promoting Control of Asthma Appendix E: Device Technique Medications: Inhalation Devices Adapted with permission from The Lung Association: www.lung.ca/asthma/manage/devices.html
More informationProcess Drift and it s Resolution in the Manufacture of Drug Products. MDI s and DPI s Metered Dose Inhalations and Dry Powder Inhalations
Process Drift and it s Resolution in the Manufacture of Drug Products MDI s and DPI s Metered Dose Inhalations and Dry Powder Inhalations Ed Warner, Merck MMD December 2, 2010 PQRI-FDA Workshop on Process
More informationAppendix M: Device Technique
Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Appendix M: Device Technique Medications: Inhalation Devices Medications come in many forms.
More informationThe Role of EPAG in Standards and Regulatory Guidance Development
The Role of EPAG in Standards and Regulatory Guidance Development Jolyon P. Mitchell on behalf of EPAG Session 4: The Remit, Activities and Achievements of The European Pharmaceutical Aerosols Group 1
More informationSELECTING A DOSAGE FORM FOR DRUG DELIVERY TO THE LUNGS. Dr. Jay T. Holt, Ph.D., Sr. Director, Inhalation & Analytical
SELECTING A DOSAGE FORM FOR DRUG DELIVERY TO THE LUNGS Dr. Jay T. Holt, Ph.D., Sr. Director, Inhalation & Analytical www.cirruspharm.com February 2014 INTRODUCTION Cirrus, a Kemwell company, is frequently
More informationInhalation devices, proper technique and cleaning
Preventing Your Symptoms and Taking Your Medications Inhalation devices, proper technique and cleaning Knowing how to use your medications properly is important because inhaled drugs are meant to get directly
More informationCase Study 1: Pharmaceutical Development of EXUBERA
Case Study 1: Pharmaceutical Development of EXUBERA Nancy Harper, PhD Research Fellow, Parenteral Development Center of Emphasis Pfizer Global R&D IPAC-RS Conference November 2006 1 EXUBERA Insulin human
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS
European Medicines Agency Inspections London, 16 February 2005 Doc Ref.: EMEA/CHMP/QWP/49313/2005 corr. COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF
More informationBreezhaler. Open to see clear capsule. How do I use my Breezhaler? Care of my Breezhaler
Breezhaler 3 Pull cap off Press buttons once and release Breathe in rapidly and steadily. Hold. Open. Place capsule in chamber. Close (click). Breathe out 4 Open to see clear capsule. If not all clear
More informationAcUMEDr. Arc Wrist Tower. For Wrist Arthroscopy And Fracture Reduction
AcUMEDr Arc Wrist Tower For Wrist Arthroscopy And Fracture Reduction Arc Wrist Tower Since 1988, Acumed has been designing solutions to the demanding situations facing orthopaedic surgeons, hospitals and
More informationPartner with the Global Leader in Drug Delivery Systems.
3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems. Hurlingham, Argentina Manufacturing Facility Experts at Commercializing Innovation Drug Delivery Systems: It s in the detail
More informationPartner with the Global Leader in Drug Delivery Systems.
3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems. Hurlingham, Argentina Manufacturing Facility Experts at Commercializing Innovation 3M is a global innovation company that
More informationAnoro Ellipta Patient Handout
Anoro Ellipta Patient Handout 1. OPEN Slide the cover down to expose the mouthpiece. You should hear a click. The counter will count down by 1 number. Do not shake this kind of inhaler. Note: If you open
More informationMODELING AN SMT LINE TO IMPROVE THROUGHPUT
As originally published in the SMTA Proceedings MODELING AN SMT LINE TO IMPROVE THROUGHPUT Gregory Vance Rockwell Automation, Inc. Mayfield Heights, OH, USA gjvance@ra.rockwell.com Todd Vick Universal
More informationInfluence of blender type on the performance of ternary dry powder inhaler formulations
Institute of Pharmacy Kiel University Influence of blender type on the performance of ternary dry powder inhaler formulations Mats Hertel Theoretical background Binary formulation: 1 st blending Ternary
More informationCaption: The equipment required for testing Fluticasone Propionate (FP) Inhalation Powder in line with a new product-specific monograph (USP36-NF31).
Product-specific FDA guidance, and product-specific pharmacopeial monographs, point to the use of test equipment, some of which isn t included in the general USP/Ph. Eur. chapters for orally inhaled products
More informationThe Medical Letter. on Drugs and Therapeutics
The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:
More information10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C
Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C Daily: Long-Term Control Corticosteroids (inhaled and systemic) Long-acting beta 2 -agonists (Serevent, Foradil) Methylxanthines
More informationINTRODUCTION. Asthma Drug Delivery - 1
Asthma Drug Delivery Laboratory Experiment Developed by: Alex Jannini, David Krause, Heather Malino and Kevin Sweeney, Rowan University, Department of Chemical Engineering Edited by: C. Stewart Slater
More informationNEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS
NEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS Douglas S. Gardenhire, Ed.D, RRT-NPS MODULE 1 Manipulate Small Volume Nebulizers by Order or Protocol 1 Objectives for Module 1 At the end of
More informationIPAC-RS/UF Orlando Inhalation Conference March 20, S.T. Horhota 1, C.B. Verkleij 2, P.J.G. Cornelissen 2, L. Bour 3, A. Sharma 3, M.
IPAC-RS/UF Orlando Inhalation Conference March 20, 2014 Case Study: Pharmacokinetics and Pharmacodynamics of Tiotropium and Salmeterol Following Parallel Administration in COPD Patients Using Different
More informationPartner with the Global Leader in Drug Delivery Systems
3M DRUG DELIVERY SYSTEMS Partner with the Global Leader in Drug Delivery Systems Loughborough, United Kingdom Manufacturing Facility Experts at Commercializing Innovation 3M: Transforming New Ideas into
More informationINTEGRATED DESIGN SPACE TO DEVELOP BETTER DPI FORMULATIONS
INTEGRATED DESIGN SPACE TO DEVELOP BETTER DPI FORMULATIONS Here, Filipa Maia, PhD, and Maria Palha, MSc, both Scientists at Hovione, report a study whose objective was to establish relationships between
More informationEverything for Inhalation
Everything for Inhalation Everything for Inhalation Inhalation drug product development at Hovione has a strong focus on formulation for Dry Powder Inhalers (DPI), particularly for capsule-based and reservoir-based
More informationIVIVC in Pediatric OIPs
IPAC-RS/UF Orlando Conference 2014 March 20, 2014 IVIVC in Pediatric OIPs Herbert Wachtel Declaration of Conflicts of Interest H. Wachtel is employee of Boehringer Ingelheim Pharma GmbH & Co. KG, Germany.
More informationADVANCIA : A TRUE PLATFORM & INNOVATIVE SYSTEM OFFERING EFFICIENT NASAL DOSE DELIVERY
ADVANCIA : A TRUE PLATFORM & INNOVATIVE SYSTEM OFFERING EFFICIENT NASAL DOSE DELIVERY Millions of people suffering from allergic rhinitis use nasal sprays manufactured by Nemera every day. In this article,
More informationDevelopment of a Dry Powder Multi-dose Inhaler using Computational Modeling
ENGINEER - Vol. XXXXII, No. 03, pp. [57-65], 2009 The Institution of Engineers, Sri Lanka Development of a Dry Powder Multi-dose Inhaler using Computational Modeling M.A.D.A.Sudeera, V.P.C.Dassanayake,
More informationLubriTose Mannitol Michael Crowley, Director of R&D, Excipients
LubriTose Mannitol Michael Crowley, Director of R&D, Excipients Introduction Michael Crowley Director of R&D Excipients 158 St. Highway 320 Norwich, NY 13815 PH 315-802-5970 Michael.Crowley@Kerry.com 2
More informationLance Listening to End-Users Clinical Use Design Validation Study
Lancing Devices Lance Listening to End-Users Clinical Use Design Validation Study Abstract +clinical + use study (CUS) conducted to validate new babylance design was meeting end-user expectations +prefaced
More informationAssessing Quality of Inhaled Products And Links to Efficacy and Safety
Assessing Quality of Inhaled Products And Links to Efficacy and Safety Prasad Peri, PhD ONDQA 2011 IPAC-RS Conference Bringing Value To The Patient In A Changing World March 30, 2011 1 Outline of the Presentation
More informationNational Transition Strategy to Replace CFC-based. MDIs with in the Commonwealth of Independent States. Paul Krajnik UNIDO, Montreal Protocol Branch
National Transition Strategy to Replace CFC-based MDIs with HFA-MDIs in the Commonwealth of Independent States Paul Krajnik UNIDO, Montreal Protocol Branch 1 Starting point: total CFC phase-out CFC phase-out
More informationGaps In Successful EHR Implementations: The Challenges & Successes Of Providers In The Marketplace
Gaps In Successful EHR Implementations: The Challenges & Successes Of Providers In The Marketplace A White Paper By Credible Behavioral Health, Inc. October 2016 Contents I. Introduction... 3 Ii. Findings
More informationInternational Pharmaceutical Aerosol Consortium on Regulation and Science
International Pharmaceutical Aerosol Consortium on Regulation and Science 1500 K Street NW Washington DC 20005 Telephone +1 202 230 5607 Fax +1 202 842 8465 Email info@ipacrs.org Web www.ipacrs.org Submitted
More informationUniversity of Groningen. Optimisation of dry powder inhalation Boer, Anne Haaije de
University of Groningen Optimisation of dry powder inhalation Boer, Anne Haaije de IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More informationSub-components in Nicotine cessation products?
Sub-components in Nicotine cessation products? Mr Arun Sarda, Director of Quality and Regulatory Affairs Member of the HEITKAMP & THUMANN GROUP Regulatory approval of sub-components in nicotine cessation
More informationSMARTPILOT FOR YPSOMATE: TRANSFORMING A PROVEN AUTOINJECTOR INTO A FULLY CONNECTED DEVICE
SMARTPILOT FOR YPSOMATE: TRANSFORMING A PROVEN AUTOINJECTOR INTO A FULLY CONNECTED DEVICE In this article, Orfeo Niedermann, Business Development Director, Ypsomed Delivery Systems, provides insights into
More informationProduct Specifications and Usage Information P4405, P4410, & P4420 Genesys 30 Dosimeter Holder System
DESCRIPTION The Thermo Genesys 30 Spectrophotometer (G30) is supplied with specially designed dosimeter holders to fit a variety of dosimeters, including the B3 DoseStix and B3 WINdose dosimeters. The
More informationNebuTech nebulizer from Salter. Striving to be #1 IN PATIENT SATISFACTION. To help you and your patients. easy. breathe
nebulizer from Salter To help you and your patients breathe easy Striving to be #1 IN PATIENT SATISFACTION nebulizer from Salter Let go to work for you and your patients today. Performance Versatility
More informationHARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS IN INHALATION
HARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS IN INHALATION 2 3 QUALICAPS HISTORY Over one hundred years of experience in the manufacturing and filling of hard two-piece capsules Qualicaps
More informationExcipient Considerations for Continuous Manufacturing Implementation
Excipient Considerations for Continuous Manufacturing Implementation FDA-PQRI Conference March 22-24, 2017 David R. Schoneker Director of Global Regulatory Affairs Email: dschoneker@colorcon.com 1 Continuous
More informationPocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals
Pocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals Endorsed by NHSGGC Respiratory Managed Clinical Network; June 2016 Designed by Medical Illustration Services Contents
More informationFor personal use only. Investor Briefing. Bayswater, 1 st December 2016
Investor Briefing Bayswater, 1 st December 2016 Introduction Samantha Cheetham Chief Executive Officer To be an innovative leader in the dental industry, developing our people and partnering with dentists
More informationBoehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence
Boehringer Ingelheim BioXcellence Producing Value Global Contract Manufacturing Excellence Your World Class Contract Manufacturer Boehringer Ingelheim BioXcellence Producing Value Boehringer Ingelheim
More informationYour Inhaler Devices & You
1 Your Inhaler Devices & You COUNSEL ON THE APPROPRIATE USE OF A: METERED DOSE INHALER (MDI) DRY POWDER INHALER (DPI) DISCUSS THE APPROPRIATE USAGE OF A PEAK FLOW METER AND SPACER/HOLDING CHAMBER DEVICE
More informationInhalation Product Research at FDA
Inhalation Product Research at FDA Changning Guo Ph. D., Chemist Division of Pharmaceutical Analysis FDA/CDER/OPS/OTR 2016 GPhA CMC workshop, May 17, 2016 Disclaimer: This presentation reflects the views
More informationGMMMG Asthma Formulary Inhaler Options August 2017
Regular Preventer Beclometasone Beclometasone Beclometasone Brand name Qvar Easi-Breathe Clenil Modulite Easyhaler Device MDI MDI DPI Strengths 50 microgram 100 microgram 200 microgram Adult asthma 2 inhalations
More informationIROC Liver Phantom. Guidelines for Planning and Irradiating the IROC Liver Phantom. Revised July 2015
IROC Liver Phantom Guidelines for Planning and Irradiating the IROC Liver Phantom. Revised July 2015 The study groups are requests that each institution keep the phantom for no more than 2 weeks. During
More informationLava. Chairside Oral Scanner C.O.S. The Future in Motion
Lava Chairside Oral Scanner C.O.S. The Future in Motion A Brilliant Impression of the Future. What if you could instantaneously view impressions in awe-inspiring detail and turn an unpleasant procedure
More informationA NEW, ADVANCED HIGH- THROUGHPUT SYSTEM FOR AUTOMATED INHALER TESTING
A NEW, ADVANCED HIGH- THROUGHPUT SYSTEM FOR AUTOMATED INHALER TESTING Two years ago, Novi Systems Ltd set out to shake up the inhaler automation market. On December 8th, 2015, at the Drug Delivery to the
More informationCapturing lightning In A Bottle
Capturing lightning In A Bottle Featured In: Manufacturing & Capabilities I Facility of the Year I ISPE By Stephen Hall, Senior Director, Engineering, MannKind Corporation; Juergen Martens, Chief Technical
More informationCOMPARISON OF THE RESPIRABLE FRACTION FROM THREE DIFERENT DPI DEVICES
COMPARISON OF THE RESPIRABLE FRACTION FROM THREE DIFERENT DPI DEVICES Miriam Sanz Cermeño and Helena Maria Cabral Marques UCTF, Faculdade de Farmácia, Universidade de Lisboa, PORTUGAL 1. Introduction Inhalation
More informationHow can I benefit most from my COPD medications?
Fact Sheet: COPD Medications and Delivery Devices How can I benefit most from my COPD medications? COPD medications can improve your symptoms. By taking the right medication at the right time, you can
More informationSINCE 1978 MADE IN THE USA PRO 7000 SERIES SUPPLEMENTARY MACHINES MEDICAL SERIES. engineered for success
SINCE 1978 MADE IN THE USA 1 TM PRO 7000 SERIES SUPPLEMENTARY MACHINES MEDICAL SERIES ENGINEERED FOR SPORTS PERFORMANCE MAGNUM S PRO 7000 SERIES Thirty years of industry experience, innovation, and customer
More informationQuantos Powder Dosing Automated Powder Dosing Unmatched accuracy Assured user safety Increased efficiency
Quantos Powder Dosing Automated Powder Dosing Unmatched accuracy Assured user safety Increased efficiency Simplified Powder Dosing for Maximum Accuracy and Safety The Powder Challenge The Powder Challenge
More informationONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE
CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE AT KANTAR HEALTH, ONCOLOGY
More informationCOPD Device Workshop. Summary. Role of inhaler device in COPD. Why use inhaler device in COPD?
Part 1 Role of inhaler device in COPD COPD Device Workshop Dr Philip Lee Respiratory and Sleep Physician St George Hospital, Sydney Part 2 Part 3 Part 4 Incorrect inhaler technique-adverse clinical outcomes
More informationUnderstanding cascade impaction and its importance for inhaler testing
Understanding cascade impaction and its importance for inhaler testing Mark Copley, Technical Sales Manager Inhalation product development is an important area of activity for the pharmaceutical sector.
More informationOverview Internal review
Overview Internal review Presentation title: QRM, It s not all about the assessment Track title: Day 1, Session 2 Speaker: Seamus Orr Date / Time: 10 August 2015, 14.30 15.00 Time allotted: 30 minutes
More informationProduct Guide. MSP Corporation Rice Creek Parkway, Suite 300. Shoreview, Minnesota 55126, U.S.A. Phone: Fax:
Product Guide inhalertesting MSP Corporation 5910 Rice Creek Parkway, Suite 300 Shoreview, Minnesota 55126, U.S.A. Phone: 651.287.8100 Fax: 651.287.8140 sales@mspcorp.com www.mspcorp.com About This Guide
More informationThermo Scientific ART Pipette Tips. superior tips. for any application, any pipette
Thermo Scientific ART Pipette Tips superior tips for any application, any pipette How do we make it easy to select exceptional tips for all the pipette brands you use? It's ART. The Thermo Scientific ART
More information8 Performing Medical Procedures
8 The Terason usmart3200t Ultrasound System can aid in performing medical procedures such as biopsies. Depending on whether you purchased the additional equipment required for these procedures, you may
More informationCurrent Challenges and Opportunities in Demonstrating Bioequivalence
Current Challenges and Opportunities in Demonstrating Bioequivalence Gur Jai Pal Singh, Ph.D. Watson Laboratories, Inc. Corona, California, USA Demonstrating Bioequivalence of Locally Acting Orally Inhaled
More informationWE VE MADE FIXED FULL-ARCH RESTORATIONS A SNAP. NO SCREWS. NO CEMENT. NO COMPROMISES.
WE VE MADE FIXED FULL-ARCH RESTORATIONS A SNAP. NO SCREWS. NO CEMENT. NO COMPROMISES. LOCATOR F-Tx A NEW WAY TO THINK ABOUT FIXED FULL-ARCH RESTORATIONS. LOCATOR F-Tx IS A SIMPLIFIED, TIME SAVING SOLUTION
More informationTRAINING DEVICE OPPORTUNITIES AND SOLUTIONS FOR A CHANGING RESPIRATORY MARKET
TRAINING DEVICE OPPORTUNITIES AND SOLUTIONS FOR A CHANGING RESPIRATORY MARKET Building on his previous articles in ONdrugDelivery on training devices and drug delivery device education, here, Joe Reynolds,
More informationCOMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium
COMMENTS on a draft Guidance for Industry Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products Chemistry, Manufacturing, and Controls Documentation (Docket No. 99D-1454) Submitted by
More informationISO INTERNATIONAL STANDARD. Dentistry Reversible-irreversible hydrocolloid impression material systems
INTERNATIONAL STANDARD ISO 13716 First edition 1999-05-01 Dentistry Reversible-irreversible hydrocolloid impression material systems Art dentaire Systèmes de produits pour empreintes à base d'hydrocolloïdes
More informationSummary of ACEA Tests. ACEA Comments
8 th TEG FlexPLI Meeting on 19.05.2009 Offices of TÜV Rheinland, Cologne Summary of ACEA Tests ACEA Comments Page 1 Content: ACEA previous and latest test series Problems related to Flex-GTα and Flex-GTR
More informationOPTIMISING ANALYTICAL STRATEGIES FOR THE DEMONSTRATION OF BIOEQUIVALENCE IN A GENERIC NEBULISER
OPTIMISING ANALYTICAL STRATEGIES FOR THE DEMONSTRATION OF BIOEQUIVALENCE IN A GENERIC NEBULISER US FDA guidance for the in vitro demonstration of bioequivalence in a generic nebuliser directly references
More information15 cm Reservoir Tubing. 210 cm Tubing
12 Aerosol Therapy nebulisers AEROSOL THERAPY MICRO MIST SMALL VOLUME NEBULISER The MICRO MIST small volume nebuliser is designed for performance and economy and can be used for hand-held or in-line treatments.
More informationMDI Bonanza. Dwayne Griffin, DO
MDI Bonanza Dwayne Griffin, DO Bonanza 3. A MDI costing $200 - $500 per month SISYPHUS MDI Griffin Mountain Evolution of Deliver Systems for COPD in the US 2003 2009 2011 2013 2004 2012 2014 Prescribing
More informationThe Use of Physics-Based Modeling to Better Design Drug- Device Interface. Yoen-Ju Son, PhD Merck Research Laboratory, Summit, NJ
The Use of Physics-Based Modeling to Better Design Drug- Device Interface Yoen-Ju Son, PhD Merck Research Laboratory, Summit, NJ Presentation Outline Physics-based modeling in pharmaceutical industry Pulmonary
More informationRPC Liver Phantom Highly Conformal Stereotactic Body Radiation Therapy
RPC Liver Phantom Highly Conformal Stereotactic Body Radiation Therapy Guidelines for Planning and Irradiating the RPC Liver Phantom. Revised Dec 2005 Credentialing for this protocol requires four steps:
More informationNOVA SELECTORIZED SINGLE AND DUAL STATIONS
NOVA SELECTORIZED SINGLE AND DUAL STATIONS 4 key features of nautilus nova equipment Increased visibility through transparent weight towers. Integrated 5 lb. increment add-on weight system inside fully-shielded
More informationUniversity of Groningen. Technology in practice Lexmond, Anne
University of Groningen Technology in practice Lexmond, Anne IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document
More informationInhaler technique reminder cards
Inhaler technique reminder cards Produced by the Medicines Optimisation Team NHS NEW Devon CCG For further information visit: www.newdevonccg.nhs.uk/information-for-patients/medicines-and-treatments/100073
More informationMAKE THE CLEAR CHOICE. IV Products and Accessories Designed to Help Maximize Clinical Performance While Optimizing Savings
MAKE THE CLEAR CHOICE. IV Products and Accessories Designed to Help Maximize Clinical Performance While Optimizing Savings EXCEPTIONAL QUALITY, PERFORMANCE AND VALUE. Infuse medications and fluids accurately
More informationDräger Alcotest 6820 Alcohol Screening Device
Dräger Alcotest 6820 Alcohol Screening Device Dräger Alcotest 6820 is the logical successor to the successful Alcotest 6810. The compact hand-held measuring instrument Alcotest is quickly ready for use
More informationBeclometasone dipropionate (BDP) Prophylactic management of mild, moderate or severe asthma in adults
CLENIL MODULITE Beclometasone dipropionate (BDP) Prophylactic management of mild, moderate or severe asthma in adults Corticosteroids for the treatment of chronic asthma in adults and children aged 12
More informationHUMAN FACTORS ENGINEERING OF SELF-INJECTION DEVICES
HUMAN FACTORS ENGINEERING OF SELF-INJECTION DEVICES In this overview, Tobias Nemeth, Business Development Manager, Ypsomed Delivery Systems, provides a useful insight into human factors engineering. The
More informationIROC Lung Phantom 3D CRT / IMRT. Guidelines for Planning and Irradiating the IROC Lung Phantom. Revised Dec 2015
IROC Lung Phantom 3D CRT / IMRT Guidelines for Planning and Irradiating the IROC Lung Phantom. Revised Dec 2015 The IROC requests that each institution keep the phantom for no more than 2 weeks. During
More informationYour Partner in Healing
Your Partner in Healing Euromed provides all functions necessary for market-ready hydrocolloid wound dressings. With fully integrated services, Euromed is one of a select few custom hydrocolloid manufacturers
More informationPublic Assessment Report Scientific discussion. Flumetor (salmeterol xinafoate/fluticasone propionate) SE/H/1068/01-02/DC
Public Assessment Report Scientific discussion Flumetor (salmeterol xinafoate/fluticasone propionate) SE/H/1068/01-02/DC This module reflects the scientific discussion for the approval of Flumetor. The
More informationYear in review. Vit Perlik Director of Regulatory Science and Clinical Development
Year in review Vit Perlik Director of Regulatory Science and Clinical Development Content Year in review Covering September 2013 to September 2014 Where the regulation goes selection of events for illustration
More informationThe Montreal Protocol and the Phase-out of CFC-based Metered Dose Inhalers. Paul Krajnik UNIDO, Montreal Protocol Branch
The Montreal Protocol and the Phase-out of CFC-based Metered Dose Inhalers Paul Krajnik UNIDO, Montreal Protocol Branch 1 The Montreal Protocol Binding international agreement for the preservation and
More informationThe influence of lactose particle size on dry powder inhalation performance
The influence of lactose particle size on dry powder inhalation performance MCC Starch Lactose Inhalation Superdisintegrants 1 Introduction In most dry powder inhalation (DPI) formulations carriers are
More informationGuide to Inhaled Treatment Choices
Guide to Inhaled Treatment Choices Note: this is guidance only, it is important to consider which device is best suited to the patient. This may NOT be the first line choice (but should be on the joint
More informationUK X-FEL National Laboratory Perspective
UK X-FEL National Laboratory Perspective Susan Smith STFC ASTeC IoP PAB/STFC Workshop Towards a UK XFEL 16 th February 2016 Content Overview STFC national labs capabilities FEL R&D Underpinning accelerator
More informationGuide to Inhaled Treatment Choices
Guide to Inhaled Treatment Choices Note: this is guidance only, it is important to consider which device is best suited to the patient. This may NOT be the first line choice (but should be on the joint
More informationChapter 1 Quiz. Name: 1. List six characteristics of today s manufacturing environment.
Chapter 1 Quiz Name: 1. List six characteristics of today s manufacturing environment. 2. What are the four steps that products go through from raw material and components to finished products as discussed
More informationEPAG Perspective - Regulatory Advances Related to Nasal Spray Pumps. Dr G.Williams Nasal Drug Delivery Management Forum London, 15 Apr 2010
1 EPAG Perspective - Regulatory Advances Related to Nasal Spray Pumps Dr G.Williams Nasal Drug Delivery Management Forum London, 15 Apr 2010 Overview 2 EPAG, what is it?, background, this project Regulatory
More information